Loading Events

« All Events

SUP 004 – Good Distribution Practice, 11 February 2026

February 11, 2026 @ 8:00 am - 5:00 pm

About Course

Good Distribution Practice (GDP) Training will enable participants to acquire the essential knowledge and skills required to ensure the integrity, safety, and quality of pharmaceutical products throughout the supply chain.  This training will provide participants with insights into the best practices in handling, storage, and distribution to maintain compliance with regulatory requirements and industry standards. The training will support the organization’s efforts in strengthening its supply chain management, regulatory compliance, and risk mitigation strategies. By implementing GDP principles effectively, organizations can build trust with regulatory authorities, business partners, and customers while mitigating risks associated with product mishandling, counterfeiting, and quality deviations.

What Will You Learn?

  • Enable participants to implement and enhance Good Distribution Practice (GDP) principles in their organizations, ensuring compliance with regulatory standards and maintaining the integrity of the pharmaceutical supply chain.
  • Equip participants with the knowledge and skills to manage the handling, storage, and distribution of pharmaceutical products while minimizing risks related to product quality, contamination, and counterfeiting.
  • Train participants in identifying and mitigating potential risks in distribution processes including supply chain disruptions, non-compliance with regulatory requirements, and product recalls.
  • Enable participants to establish and maintain robust quality assurance and risk management systems in line with GDP guidelines to ensure continuous improvement and operational efficiency.
  • Provide participants with a comprehensive understanding of regulatory requirements for the storage and distribution of pharmaceuticals products including compliance with national regulatory requirements governing dangerous drugs, scheduled poisons, and psychotropic substances.

Details